United States Nano Biotechnology Market Report & Forecast 2021-2027

SKU ID :QYR-19562685 | Published Date: 18-Nov-2021 | No. of pages: 93
1 Introduction to Research & Analysis Reports 1.1 Nano Biotechnology Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Nano Biotechnology Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Nano Biotechnology Overall Market Size 2.1 United States Nano Biotechnology Market Size: 2021 VS 2027 2.2 United States Nano Biotechnology Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Nano Biotechnology Players in United States Market 3.2 Top United States Nano Biotechnology Companies Ranked by Revenue 3.3 United States Nano Biotechnology Revenue by Companies 3.4 Top 3 and Top 5 Nano Biotechnology Companies in United States Market, by Revenue in 2020 3.5 Companies Nano Biotechnology Product Type 3.6 Tier 1, Tier 2 and Tier 3 Nano Biotechnology Players in United States Market 3.6.1 List of Tier 1 Nano Biotechnology Companies in United States 3.6.2 List of Tier 2 and Tier 3 Nano Biotechnology Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Nano Biotechnology Market Size Markets, 2021 & 2027 4.1.2 0-10 nm 4.1.3 10-100 nm 4.2 By Type - United States Nano Biotechnology Revenue & Forecasts 4.2.1 By Type - United States Nano Biotechnology Revenue, 2016-2021 4.2.2 By Type - United States Nano Biotechnology Revenue, 2022-2027 4.2.3 By Type - United States Nano Biotechnology Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Nano Biotechnology Market Size, 2021 & 2027 5.1.2 Pharmaceuticals 5.1.3 Medical Devices 5.1.4 Medical Research 5.1.5 Other 5.2 By Application - United States Nano Biotechnology Revenue & Forecasts 5.2.1 By Application - United States Nano Biotechnology Revenue, 2016-2021 5.2.2 By Application - United States Nano Biotechnology Revenue, 2022-2027 5.2.3 By Application - United States Nano Biotechnology Revenue Market Share, 2016-2027 6 Nano Biotechnology Companies Profiles 6.1 Aduro BioTech 6.1.1 Aduro BioTech Company Details 6.1.2 Aduro BioTech Business Overview 6.1.3 Aduro BioTech Nano Biotechnology Introduction 6.1.4 Aduro BioTech Nano Biotechnology Revenue in United States Market (2016-2021) 6.1.5 Aduro BioTech Recent Developments 6.2 Calando Pharmaceuticals 6.2.1 Calando Pharmaceuticals Company Details 6.2.2 Calando Pharmaceuticals Business Overview 6.2.3 Calando Pharmaceuticals Nano Biotechnology Introduction 6.2.4 Calando Pharmaceuticals Nano Biotechnology Revenue in United States Market (2016-2021) 6.2.5 Calando Pharmaceuticals Recent Developments 6.3 Biosante Phosphate Pharmaceuticals 6.3.1 Biosante Phosphate Pharmaceuticals Company Details 6.3.2 Biosante Phosphate Pharmaceuticals Business Overview 6.3.3 Biosante Phosphate Pharmaceuticals Nano Biotechnology Introduction 6.3.4 Biosante Phosphate Pharmaceuticals Nano Biotechnology Revenue in United States Market (2016-2021) 6.3.5 Biosante Phosphate Pharmaceuticals Recent Developments 6.4 Celgene Corporation 6.4.1 Celgene Corporation Company Details 6.4.2 Celgene Corporation Business Overview 6.4.3 Celgene Corporation Nano Biotechnology Introduction 6.4.4 Celgene Corporation Nano Biotechnology Revenue in United States Market (2016-2021) 6.4.5 Celgene Corporation Recent Developments 6.5 Elan Pharmaceuticals 6.5.1 Elan Pharmaceuticals Company Details 6.5.2 Elan Pharmaceuticals Business Overview 6.5.3 Elan Pharmaceuticals Nano Biotechnology Introduction 6.5.4 Elan Pharmaceuticals Nano Biotechnology Revenue in United States Market (2016-2021) 6.5.5 Elan Pharmaceuticals Recent Developments 6.6 Flamel Technologies 6.6.1 Flamel Technologies Company Details 6.6.2 Flamel Technologies Business Overview 6.6.3 Flamel Technologies Nano Biotechnology Introduction 6.6.4 Flamel Technologies Nano Biotechnology Revenue in United States Market (2016-2021) 6.6.5 Flamel Technologies Recent Developments 6.7 Nanophase Technologies 6.7.1 Nanophase Technologies Company Details 6.7.2 Nanophase Technologies Business Overview 6.7.3 Nanophase Technologies Nano Biotechnology Introduction 6.7.4 Nanophase Technologies Nano Biotechnology Revenue in United States Market (2016-2021) 6.7.5 Nanophase Technologies Recent Developments 6.8 Sigma Aldrich Company 6.8.1 Sigma Aldrich Company Company Details 6.8.2 Sigma Aldrich Company Business Overview 6.8.3 Sigma Aldrich Company Nano Biotechnology Introduction 6.8.4 Sigma Aldrich Company Nano Biotechnology Revenue in United States Market (2016-2021) 6.8.5 Sigma Aldrich Company Recent Developments 6.9 Dendritic Nanotechnologies 6.9.1 Dendritic Nanotechnologies Company Details 6.9.2 Dendritic Nanotechnologies Business Overview 6.9.3 Dendritic Nanotechnologies Nano Biotechnology Introduction 6.9.4 Dendritic Nanotechnologies Nano Biotechnology Revenue in United States Market (2016-2021) 6.9.5 Dendritic Nanotechnologies Recent Developments 6.10 SkyePharma Pharmaceuticals 6.10.1 SkyePharma Pharmaceuticals Company Details 6.10.2 SkyePharma Pharmaceuticals Business Overview 6.10.3 SkyePharma Pharmaceuticals Nano Biotechnology Introduction 6.10.4 SkyePharma Pharmaceuticals Nano Biotechnology Revenue in United States Market (2016-2021) 6.10.5 SkyePharma Pharmaceuticals Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer
List of Tables Table 1. Nano Biotechnology Market Opportunities & Trends in United States Market Table 2. Nano Biotechnology Market Drivers in United States Market Table 3. Nano Biotechnology Market Restraints in United States Market Table 4. Key Players of Nano Biotechnology in United States Market Table 5. Top Nano Biotechnology Players in United States Market, Ranking by Revenue (2019) Table 6. United States Nano Biotechnology Revenue by Companies, (US$, Mn), 2016-2021 Table 7. United States Nano Biotechnology Revenue Share by Companies, 2016-2021 Table 8. Companies Nano Biotechnology Product Type Table 9. List of Tier 1 Nano Biotechnology Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Nano Biotechnology Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type – United States Nano Biotechnology Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - United States Nano Biotechnology Revenue (US$, Mn), 2016-2021 Table 13. By Type - United States Nano Biotechnology Revenue (US$, Mn), 2022-2027 Table 14. By Application – United States Nano Biotechnology Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - United States Nano Biotechnology Revenue (US$, Mn), 2016-2021 Table 16. By Application - United States Nano Biotechnology Revenue (US$, Mn), 2022-2027 Table 17. Aduro BioTech Company Details Table 18. Aduro BioTech Business Overview Table 19. Aduro BioTech Nano Biotechnology Product Table 20. Aduro BioTech Nano Biotechnology Revenue in United States Market (2016-2021) & (US$ Million) Table 21. Aduro BioTech Recent Developments Table 22. Calando Pharmaceuticals Company Details Table 23. Calando Pharmaceuticals Business Overview Table 24. Calando Pharmaceuticals Nano Biotechnology Product Table 25. Calando Pharmaceuticals Nano Biotechnology Revenue in United States Market (2016-2021) & (US$ Million) Table 26. Calando Pharmaceuticals Recent Developments Table 27. Biosante Phosphate Pharmaceuticals Company Details Table 28. Biosante Phosphate Pharmaceuticals Business Overview Table 29. Biosante Phosphate Pharmaceuticals Nano Biotechnology Product Table 30. Biosante Phosphate Pharmaceuticals Nano Biotechnology Revenue in United States Market (2016-2021) & (US$ Million) Table 31. Biosante Phosphate Pharmaceuticals Recent Developments Table 32. Celgene Corporation Company Details Table 33. Celgene Corporation Business Overview Table 34. Celgene Corporation Nano Biotechnology Product Table 35. Celgene Corporation Nano Biotechnology Revenue in United States Market (2016-2021) & (US$ Million) Table 36. Celgene Corporation Recent Developments Table 37. Elan Pharmaceuticals Company Details Table 38. Elan Pharmaceuticals Business Overview Table 39. Elan Pharmaceuticals Nano Biotechnology Product Table 40. Elan Pharmaceuticals Nano Biotechnology Revenue in United States Market (2016-2021) & (US$ Million) Table 41. Elan Pharmaceuticals Recent Developments Table 42. Flamel Technologies Company Details Table 43. Flamel Technologies Business Overview Table 44. Flamel Technologies Nano Biotechnology Product Table 45. Flamel Technologies Nano Biotechnology Revenue in United States Market (2016-2021) & (US$ Million) Table 46. Flamel Technologies Recent Developments Table 47. Nanophase Technologies Company Details Table 48. Nanophase Technologies Business Overview Table 49. Nanophase Technologies Nano Biotechnology Product Table 50. Nanophase Technologies Nano Biotechnology Revenue in United States Market (2016-2021) & (US$ Million) Table 51. Nanophase Technologies Recent Developments Table 52. Sigma Aldrich Company Company Details Table 53. Sigma Aldrich Company Business Overview Table 54. Sigma Aldrich Company Nano Biotechnology Product Table 55. Sigma Aldrich Company Nano Biotechnology Revenue in United States Market (2016-2021) & (US$ Million) Table 56. Sigma Aldrich Company Recent Developments Table 57. Dendritic Nanotechnologies Company Details Table 58. Dendritic Nanotechnologies Business Overview Table 59. Dendritic Nanotechnologies Nano Biotechnology Product Table 60. Dendritic Nanotechnologies Nano Biotechnology Revenue in United States Market (2016-2021) & (US$ Million) Table 61. Dendritic Nanotechnologies Recent Developments Table 62. SkyePharma Pharmaceuticals Company Details Table 63. SkyePharma Pharmaceuticals Business Overview Table 64. SkyePharma Pharmaceuticals Nano Biotechnology Product Table 65. SkyePharma Pharmaceuticals Nano Biotechnology Revenue in United States Market (2016-2021) & (US$ Million) Table 66. SkyePharma Pharmaceuticals Recent Developments List of Figures Figure 1. Nano Biotechnology Segment by Type Figure 2. Nano Biotechnology Segment by Application Figure 3. United States Nano Biotechnology Market Overview: 2020 Figure 4. United States Nano Biotechnology Market Size: 2021 VS 2027 (US$, Mn) Figure 5. United States Nano Biotechnology Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Nano Biotechnology Revenue in 2020 Figure 7. By Type - United States Nano Biotechnology Revenue Market Share, 2016-2027 Figure 8. By Application - United States Nano Biotechnology Revenue Market Share, 2016-2027 Figure 9. Aduro BioTech Nano Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. Calando Pharmaceuticals Nano Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Biosante Phosphate Pharmaceuticals Nano Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Celgene Corporation Nano Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. Elan Pharmaceuticals Nano Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. Flamel Technologies Nano Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 15. Nanophase Technologies Nano Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 16. Sigma Aldrich Company Nano Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 17. Dendritic Nanotechnologies Nano Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 18. SkyePharma Pharmaceuticals Nano Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Aduro BioTech Calando Pharmaceuticals Biosante Phosphate Pharmaceuticals Celgene Corporation Elan Pharmaceuticals Flamel Technologies Nanophase Technologies Sigma Aldrich Company Dendritic Nanotechnologies SkyePharma Pharmaceuticals
  • PRICE
  • $3400
    $6800
    $5100

Our Clients